| Schedule of Redeemable Noncontrolling Interests |
A summary of the Company’s redeemable noncontrolling interests on its consolidated balance sheets is set forth below: | | | | | | | | | | | | | | | | | | | | | | | | | | At June 30, 2026 | | At December 31, 2025 | | | Redeemable noncontrolling interest - DaVinci | $ | 3,496,477 | | | $ | 3,701,637 | | | | Redeemable noncontrolling interest - Medici | 1,444,350 | | | 1,398,166 | | | | Redeemable noncontrolling interest - Vermeer | 1,888,913 | | | 1,922,431 | | | | Redeemable noncontrolling interest - Fontana | 513,613 | | | 579,858 | | | | Redeemable noncontrolling interests | $ | 7,343,353 | | | $ | 7,602,092 | | | | | | | | |
A summary of the Company’s redeemable noncontrolling interests on its consolidated statements of operations is set forth below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Six months ended | | | | June 30, 2026 | | June 30, 2025 | | June 30, 2026 | | June 30, 2025 | | | Redeemable noncontrolling interest - DaVinci | $ | 205,117 | | | $ | 218,453 | | | $ | 362,017 | | | $ | 106,012 | | | | Redeemable noncontrolling interest - Medici | 26,313 | | | 38,993 | | | 46,120 | | | 54,156 | | | | Redeemable noncontrolling interest - Vermeer | 64,783 | | | 57,425 | | | 116,482 | | | (49,655) | | | | Redeemable noncontrolling interest - Fontana | 19,047 | | | 13,468 | | | 13,092 | | | 22,574 | | | | Net income (loss) attributable to redeemable noncontrolling interests (1) | $ | 315,260 | | | $ | 328,339 | | | $ | 537,711 | | | $ | 133,087 | | | | | | | | | | | | |
The activity in redeemable noncontrolling interest – DaVinci is detailed in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Six months ended | | | | June 30, 2026 | | June 30, 2025 | | June 30, 2026 | | June 30, 2025 | | | Beginning balance | $ | 3,291,360 | | | $ | 2,992,338 | | | $ | 3,701,637 | | | $ | 3,061,708 | | | | Redemption of shares from redeemable noncontrolling interests, net of adjustments | — | | | — | | | (649,164) | | | (26,929) | | | | Sale of shares to redeemable noncontrolling interests, net of adjustments | — | | | — | | | — | | | 70,000 | | | | Net income (loss) attributable to redeemable noncontrolling interest, net of consolidation adjustments | 205,117 | | | 218,453 | | | 444,004 | | | 106,012 | | | | | | | | | | | | | | Ending balance | $ | 3,496,477 | | | $ | 3,210,791 | | | $ | 3,496,477 | | | $ | 3,210,791 | | | | | | | | | | | | |
The activity in redeemable noncontrolling interest – Medici is detailed in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Six months ended | | | | June 30, 2026 | | June 30, 2025 | | June 30, 2026 | | June 30, 2025 | | | Beginning balance | $ | 1,433,068 | | | $ | 1,469,402 | | | $ | 1,398,166 | | | $ | 1,646,745 | | | | Redemption of shares from redeemable noncontrolling interests, net of adjustments | (15,031) | | | (56,734) | | | (45,936) | | | (295,529) | | | | Sale of shares to redeemable noncontrolling interests | — | | | 81,329 | | | 46,000 | | | 142,932 | | | | Net income (loss) attributable to redeemable noncontrolling interest | 26,313 | | | 38,993 | | | 46,120 | | | 54,156 | | | | Dividends on common shares | — | | | — | | | — | | | (15,314) | | | | | | | | | | | | | | Ending balance | $ | 1,444,350 | | | $ | 1,532,990 | | | $ | 1,444,350 | | | $ | 1,532,990 | | | | | | | | | | | | |
The activity in redeemable noncontrolling interest – Vermeer is detailed in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Six months ended | | | | June 30, 2026 | | June 30, 2025 | | June 30, 2026 | | June 30, 2025 | | | Beginning balance | $ | 1,824,130 | | | $ | 1,692,777 | | | $ | 1,922,431 | | | $ | 1,799,857 | | | | Dividends on common shares | — | | | — | | | (150,000) | | | — | | | | | | | | | | | | | | Net income (loss) attributable to redeemable noncontrolling interest | 64,783 | | | 57,425 | | | 116,482 | | | (49,655) | | | | | | | | | | | | | | Ending balance | $ | 1,888,913 | | | $ | 1,750,202 | | | $ | 1,888,913 | | | $ | 1,750,202 | | | | | | | | | | | | |
The activity in redeemable noncontrolling interest – Fontana is detailed in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Six months ended | | | | June 30, 2026 | | June 30, 2025 | | June 30, 2026 | | June 30, 2025 | | | Beginning balance | $ | 494,566 | | | $ | 535,656 | | | $ | 579,858 | | | $ | 469,439 | | | | Redemption of limited partner interest from redeemable noncontrolling interest | — | | | — | | | (79,337) | | | (72,044) | | | | Sale of limited partner interest to redeemable noncontrolling interest | — | | | — | | | — | | | 129,155 | | | | Net income (loss) attributable to redeemable noncontrolling interest | 19,047 | | | 13,468 | | | 13,092 | | | 22,574 | | | | | | | | | | | | | | Ending balance | $ | 513,613 | | | $ | 549,124 | | | $ | 513,613 | | | $ | 549,124 | | | | | | | | | | | | |
|